-
Subcutaneous Biologics Market Global Forecasts to 2035: Leading Players & Sales Forecast for Adocia, Alteogen, Ascendis Pharma, CD Bioparticles, Creative Biolabs, Pacira Biosciences & Xeris Biopharma - ResearchAndMarkets.com
21 Jan 2025 14:30 GMT
… address these challenges, pharmaceutical companies are utilizing innovative … Approved Subcutaneous Biologics
BENLYSTA (Human Genome Sciences)
BESREMi (PharmaEssentia)
COSENTYX … -Pacific
Alteogen
Foresee Pharmaceuticals
SUBCUTANEOUS FORMULATION TECHNOLOGIES: …
-
Subcutaneous Biologics Market, Industry Trends And Global Forecasts To 2035: Subcutaneous Biologics Set To Transform Drug Delivery And Patient Adherence
16 Jan 2025 13:02 GMT
… address these challenges, pharmaceutical companies are utilizing innovative … Approved Subcutaneous Biologics BENLYSTA (Human Genome Sciences) BESREMi (PharmaEssentia) COSENTYX … -Pacific Alteogen Foresee Pharmaceuticals SUBCUTANEOUS FORMULATION TECHNOLOGIES: …
-
Unlocking Extensive Growth Opportunities of Vasculitis Treatment Market by 2031 | RNL BIO Co., Ltd., GlaxoSmithKline plc
09 Jan 2025 09:28 GMT
… plc
• Novartis AG
• Troikaa Pharmaceuticals Ltd.
• Human Genome Sciences Inc.¸ Genentech Inc.
• F. Hoffmann … -La Roche Ltd.
• Anthera Pharmaceuticals‚ Inc …
-
Rectify Pharmaceuticals Appoints Sachiyo Minegishi as Chief Operating Officer
25 Apr 2023 11:15 GMT
Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company … held leadership roles at Aegerion Pharmaceuticals, Human Genome Sciences, Genzyme, and Amgen. She began … into the clinic.”
About Rectify Pharmaceuticals, Inc. (“Rectify”)
Rectify is …
-
Human Genome Sciences Raises $100 Million from Private Offering
21 Sep 2019 11:05 GMT
… adjustment in certain circumstances.
Human Genome Sciences plans to use the … .
General corporate purposes.
Human Genome Sciences develops pharmaceutical products to predict, prevent … William A. Haseltine, CEO, Human Genome Sciences, 9410 Key West Ave., …
-
InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical Executive, Dr. Christopher Prior, as CEO and Reports Recent Drug Discovery Highlights
25 Jan 2023 01:47 GMT
… at Aventis (now Sanofi), Pfizer, Human Genome Sciences (now GSK) and Biogen. Dr … -Announces-the-Appointment-of-Seasoned-Pharmaceutical-Executive-Dr-Christopher-Prior-as …
-
Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer
03 Dec 2024 08:00 GMT
… in forging collaborations with leading pharmaceutical and biotech companies aligns perfectly … held senior roles at Pieris Pharmaceuticals, where he established strategic deals … and completed his thesis at Human Genome Sciences. Mr. Eckhard Niemeier, CBO, …
-
Navigating Complex Partnerships: The Role of the Alliance Manager
16 Oct 2024 18:28 GMT
… of alliance management in the pharmaceutical industry.
Charles Sternberg, Associate Editor10 … .”
Key Takeaways
Collaboration is Crucial: Pharmaceutical companies need to form partnerships … and spent 9 years with Human Genome Sciences and 9 years with Lonza …
-
Reviews of Pediatric Studies Conducted under BPCA and Pediatric assessments conducted under PREA from 2012 – present
18 Sep 2024 16:26 GMT
… None
PREA
Belimumab - Benlysta
Human Genome Sciences
Medical (PDF - 6 … lamivudine, tenofovir disoproxil fumarate
Macleods Pharmaceuticals Limited, India
Medical (PDF - … suspension - Afinitor Disperz
Novartis Pharmaceuticals Corporation
Medical (PDF -10MB) …
-
Affinia Therapeutics Names New Chief Business & Financial Officer
10 Sep 2024 14:32 GMT
… Corporation, Auxilium Pharmaceuticals, Eli Lilly & Company, and Human Genome Sciences. He has … with escalating responsibilities at Auxilium Pharmaceuticals (sold to Endo), ACEA … prior to joining industry at Human Genome Sciences.
Daoud holds an M …
About
© 1995-2025